相关实验视频
Updated: Jun 22, 2025

05:39
Spontaneous Murine Model of Anaplastic Thyroid Cancer
Published on: February 3, 2023
1.6K
由C5AR1诱导的TLR1/2通路激活驱动了形甲状腺癌的扩散和转移
Bo Liu1, Yueyao Sun1, Tongyao Geng1
1Department of General Surgery, The First Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
Molecular carcinogenesis
|June 27, 2024
概括
补充C5a受体1 (C5AR1) 通过激活托尔类受体1/2通路,驱动着亚塑性甲状腺癌 (ATC) 的进展和转移. 针对miR-335-5p/C5AR1/TLR1/2轴为ATC提供了一个潜在的治疗策略.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 无塑性甲状腺癌 (ATC) 是一种具有有限治疗选择的侵袭性恶性瘤.
- 补充C5a受体1 (C5AR1) 在ATC进展中的作用在很大程度上仍未定义.
研究的目的:
- 阐明C5AR1在驱动ATC恶性进展中的作用和机制.
- 研究C5AR1和miR-335-5p之间的调控关系.
- 为了检查托尔类受体 (TLR) 1/2信号通路的参与.
主要方法:
- 在ATC组织和细胞系中评估C5AR1表达.
- 进行功能性测试 (例如,敲击,过度表达) 来评估C5AR1对ATC细胞行为的影响.
- 利用光酶记者测定和光在位杂交,以确认C5AR1-miR-335-5p相互作用.
- 研究了对TLR1/2信号通路的影响,并进行了体内研究.
主要成果:
- 在ATC中C5AR1表达升高与患者生存率差相关.
- 在C5AR1 Knockdown中抑制了ATC细胞的增殖,迁移和入侵.
- 确定了米R-335-5p作为C5AR1.1的负调节者.
- C5AR1调节了TLR1/2和MyD88水平,并且阻断TLR1/2信号取消了C5AR1的致癌作用.
- 在体内,抑制C5AR1会减少瘤生长和肺转移.
结论:
- 通过TLR1/2通路,C5AR1促进ATC瘤发生和转移.
- miR-335-5p/C5AR1轴是ATC中的一个关键调节器.
- 针对miR-335-5p/C5AR1/TLR1/2轴为ATC提供了一个有前途的治疗策略.
相关概念视频
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K
MAPK Signaling Cascades
5.4K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.4K
TGF - β Signaling Pathway
7.3K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.3K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K

